CORRECTED-India's Dr. Reddy's Q4 profit falls about 19 pct, misses estimates [Reuters]
Dr. Reddy's Laboratories Ltd (RDY)
US:NYSE Investor Relations:
drreddys.com/investors
Company Research
Source: Reuters
CORRECTED-India's Dr. Reddy's Q4 profit falls about 19 pct, misses estimates | Reuters Reuters Staff 1 Min Read (Corrects all figures except analysts’ estimates to reflect figures as per Indian Accounting Standard Rules) May 22 (Reuters) - Indian generic drugmaker Dr. Reddy’s Laboratories Ltd posted an about 19 percent fall in quarterly net profit, missing estimates, hurt by headwinds in the U.S. market. Profit for the quarter ended March 31 came in at 2.72 billion rupees ($39.98 million) versus 3.38 billion rupees a year earlier, the company said here Analysts on average estimated a profit of 3.59 billion rupees, according to Thomson Reuters data. Net sales fell slightly to 34.46 billion rupees. ($1 = 68.0400 Indian rupees) (Reporting by Arnab Paul in Bengaluru; Editing by Biju Dwarakanath) All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. Š 2018 Reuters. All Rights Reserved.
Show less
Read more
Impact Snapshot
Event Time:
RDY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RDY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RDY alerts
High impacting Dr. Reddy's Laboratories Ltd news events
Weekly update
A roundup of the hottest topics
RDY
News
- Indian shares set to open lower on fading US rate cut hopes [Reuters]Reuters
- Dr. Reddy's Laboratories Limited (NYSE: RDY) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.MarketBeat
- Aurigene Pharmaceutical Services Ltd. introduces Aurigene.AI™, an artificial intelligence (AI) and machine learning (ML) assisted drug discovery platform [Yahoo! Finance]Yahoo! Finance
- Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates [Yahoo! Finance]Yahoo! Finance
- Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates [Financial Post (Toronto, Ontario, Canada)]Financial Post
RDY
Earnings
- 1/31/24 - Beat
RDY
Sec Filings
- 4/18/24 - Form 6-K
- 4/15/24 - Form 6-K
- 4/10/24 - Form 6-K
- RDY's page on the SEC website